Pentaglobulin clinical trials
How each study uses pentaglobulin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Pentaglobin®
- 6
Studies by the year they started
7 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 7
Gruppo Italiano Trapianto di Midollo Osseo (1) · Sir Takhtasinhji General Hospital (1) · Università Politecnica delle Marche (1) · Massimo Girardis (1) · Medical University of Vienna (1) · Fakultas Kedokteran Universitas Indonesia (1) · Zekai Tahir Burak Women's Health Research and Education Hospital (1)
Often tested with
Tested in the same studies.
Chloroquine (1) · Hydroxychloroquine (1) · Lopinavir-ritonavir drug combination (1) · Rivaroxaban (1) · Candesartan (1) · Remdesivir (1) · APG101 (1) · Pentoxifylline (1)
Studies
Open first, then newest update. How each study uses pentaglobulin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Pentaglobin in CRE and PA Neutropenic InfectionsActive, not recruitingPhase 2Gruppo Italiano Trapianto di Midollo OsseoNCT03494959Written as Pentaglobin
- Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock.Status unknownPhase 3Massimo GirardisNCT04182737Written as IgM-enriched polyclonal immunoglobulins titer-based treatment
- Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)Status unknownPhase 2/3Medical University of ViennaNCT04351724Written as Pentaglobin
- Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm NeonatesCompletedPhase 4Sir Takhtasinhji General HospitalNCT03403530Written as IgM rich Immunoglobin
- IgM-Enriched Immunoglobulin for Neonatal SepsisStatus unknownPhase 3Fakultas Kedokteran Universitas IndonesiaNCT04041765Written as IgM-enriched IVIG
- Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients.CompletedPhase 2Università Politecnica delle MarcheNCT02655133Written as Pentaglobin®
- Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'Status unknownPhase 4Zekai Tahir Burak Women's Health Research and Education HospitalNCT01006499Written as Pentoxifylline, pentaglobin